Peripheral Nerve Society Guideline on processing and evaluation of nerve biopsies

Journal of the Peripheral Nervous System

Volumn 15, Issue 3, 2010, Pages 164-175

  Sommer, Claudia L ^a   Brandner, Sebastian ^a   Dyck, Peter J ^a   Harati, Yadollah ^a   Lacroix, Catherine ^a   Lammens, Martin ^a   Magy, Laurent ^a   Mellgren, Svein I ^a   Morbin, Michela ^a   Navarro, Carmen ^a   Powell, Henry C ^a   Schenone, Angelo E ^a   Tan, Ersin ^a   Urtizberea, Andoni ^b   Weis, Joachim ^a  

^a ENMC ^*

^b ENMC   (United States)

Author keywords

diagnostic performance; guideline; nerve biopsy

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOPROTEINASE; PARAFFIN;

AMYLOIDOSIS; CELL INFILTRATION; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; EVIDENCE BASED PRACTICE; FROZEN SECTION; HUMAN; IMMUNOGLOBULIN DEPOSITION; IMMUNOHISTOCHEMISTRY; INFORMED CONSENT; LABORATORY TEST; MEDICAL SOCIETY; MEDLINE; MORPHOMETRICS; NECROTIZING ARTERITIS; NERVE BIOPSY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RAGE; REFERENCE DATABASE; RISK BENEFIT ANALYSIS; SARCOIDOSIS;

EID: 78349255840     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2010.00276.x     Document Type: Conference Paper

References (90)

1. Adams D, Said G, (1998). Ultrastructural characterisation of the M protein in nerve biopsy of patients with POEMS syndrome. J Neurol Neurosurg Psychiatry 64: 809-812.
2. Ambros PF, Ambros IM, (2001). Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 37: 492-504.
3. Antoine JC, Azulay JP, Bouche P, Creange A, Fournier E, Gallouedec G, Lagueny A, Lefaucheur JP, Leger JM, Magy L, Maisonobe T, Nicolas G, Pouget J, Soichot P, Stojkovic T, Vallat JM, Verschueren A, Vial C, Viala K, (2005). Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic strategy. Guidelines of the French CIDP study group. Rev Neurol (Paris) 161: 988-996.
4. Bendszus M, Stoll G, (2005). Technology insight: visualizing peripheral nerve injury using MRI. Nat Clin Pract Neurol 1: 45-53.
5. Bennett DL, Groves M, Blake J, Holton JL, King RH, Orrell RW, Ginsberg L, Reilly MM, (2008). The use of nerve and muscle biopsy in the diagnosis of vasculitis: a 5 year retrospective study. J Neurol Neurosurg Psychiatry 79: 1376-1381.
6. Bosboom WM, Van den Berg LH, De Boer L, Van Son MJ, Veldman H, Franssen H, Logtenberg T, Wokke JH, (1999). The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy. Neurology 53: 837-845.
7. Bosboom WM, Van Den Berg LH, Franssen H, Giesbergen PC, Flach HZ, Van Putten AM, Veldman H, Wokke JH, (2001). Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain 124: 2427-2438.
8. Collins MP, Mendell JR, Periquet MI, Sahenk Z, Amato AA, Gronseth GS, Barohn RJ, Jackson CE, Kissel JT, (2000). Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 55: 636-643.
9. Collins MP, Periquet MI, Mendell JR, Sahenk Z, Nagaraja HN, Kissel JT, (2003). Nonsystemic vasculitic neuropathy: insights from a clinical cohort. Neurology 61: 623-630.
10. Deprez M, De Groote CC, Gollogly L, Reznik M, Martin JJ, (2000). Clinical and neuropathological parameters affecting the diagnostic yield of nerve biopsy. Neuromuscul Disord 10: 92-98.
11. Dyck PJ, Thomas PK, (2005). Peripheral Neuropathy. Elsevier Saunders, Philadelphia.
12. Dyck PJ, Johnson WJ, Lambert EH, O'Brien PC, (1971). Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc 46: 400-431.
13. Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R, (1986). Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 19: 425-439.
14. Dyck PJ, Norell JE, Dyck PJ, (1999). Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 53: 2113-2121.
15. Dyck PJ, Engelstad J, Norell J, Dyck PJ, (2000). Microvasculitis in non-diabetic lumbosacral radiculoplexus neuropathy (LSRPN): similarity to the diabetic variety (DLSRPN). J Neuropathol Exp Neurol 59: 525-538.
16. Dyck PJ, Dyck PJB, Engelstad, J, (2005). Pathological alterations of nerves. In: Peripheral Neuropathy., Dyck PJ, Thomas PK, (Eds). Elsevier Saunders, Philadelphia, pp 733-829.
17. Ellie E, Vital A, Steck A, Boiron JM, Vital C, Julien J, (1996). Neuropathy associated with "benign" anti-myelin-associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases. J Neurol 243: 34-43.
18. Engelhardt A, Lorler H, Neundorfer B, (1993). Immunohistochemical findings in vasculitic neuropathies. Acta Neurol Scand 87: 318-321.
19. Eurelings M, Moons KG, Notermans NC, Sasker LD, De Jager AE, Wintzen AR, Wokke JH, Van den Berg LH, (2001). Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatide. Neurology 56: 228-233.
20. Eurelings M, Notermans NC, Wokke JH, Bosboom WM, Van den Berg LH, (2002). Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy. Acta Neuropathol (Berl) 103: 107-114.
21. Eurelings M, Van Den Berg LH, Wokke JH, Franssen H, Vrancken AF, Notermans NC, (2003). Increase of sural nerve T cells in progressive axonal polyneuropathy and monoclonal gammopathy. Neurology 61: 707-709.
22. Fabrizi GM, Cavallaro T, Angiari C, Cabrini I, Taioli F, Malerba G, Bertolasi L, Rizzuto N, (2007). Charcot-Marie-Tooth disease type 2E, a disorder of the cytoskeleton. Brain 130: 394-403.
23. Flachenecker P, Janka M, Goldbrunner R, Toyka KV, (1999). Clinical outcome of sural nerve biopsy: a retrospective study. J Neurol 246: 93-96.
24. Gabreels-Festen AA, Hoogendijk JE, Meijerink PH, Gabreels FJ, Bolhuis PA, Van Beersum S, Kulkens T, Nelis E, Jennekens FG, De Visser M, Van Engelen BG, Van Broeckhoven C, Mariman EC, (1996). Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 47: 761-765.
25. Gabriel CM, Howard R, Kinsella N, Lucas S, McColl I, Saldanha G, Hall SM, Hughes RA, (2000). Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry 69: 442-446.
26. Gabriel JM, Erne B, Bernasconi L, Tosi C, Probst A, Landmann L, Steck AJ, (1998). Confocal microscopic localization of anti-myelin-associated glycoprotein autoantibodies in a patient with peripheral neuropathy initially lacking a detectable IgM gammopathy. Acta Neuropathol (Berl) 95: 540-546.
27. Gemignani F, Pavesi G, Fiocchi A, Manganelli P, Ferraccioli G, Marbini A, (1992). Peripheral neuropathy in essential mixed cryoglobulinaemia. J Neurol Neurosurg Psychiatry 55: 116-120.
28. Goebel HH, Kiefer R, Pongratz D, Schröder JM, Von Moers A, (2005). Indikation und Qualifikationskriterien für die Biopsie und präparative Aufarbeitung von Muskel- und Nervengewebeproben Konsensuspapier der Deutschen Gesellschaft für Muskelkranke (DGM). Nervenheilkunde 24: 933-935.
29. Grant IA, Benstead TJ, (2005). Differential diagnosis of polyneuropathy. In: Peripheral Neuropathy., Dyck PJ, Thomas PK, (Eds). Philadelphia Elsevier Saunders, pp 1163-80.
30. Haq RU, Fries TJ, Pendlebury WW, Kenny MJ, Badger GJ, Tandan R, (2000). Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol 57: 1745-1750.
31. Hattori N, Ichimura M, Nagamatsu M, Li M, Yamamoto K, Kumazawa K, Mitsuma T, Sobue G, (1999). Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain 122: 427-439.
32. Heuss D, Auer-Grumbach M, Haupt WF, Löscher W, Neundörfer B, Rautenstrauss B, Renaud S, Sommer C, (2008). Diagnostik bei Polyneuropathien. In: Leitlinien für Diagnostik und Therapie in der Neurologie., Diener HC, Putzki N, Berlit P, (Eds). Thieme, Stuttgart, pp 486-497.
33. Jann S, Bramerio MA, Beretta S, Koch S, Defanti CA, Toyka KV, Sommer C, (2003). Diagnostic value of sural nerve matrix metalloproteinase-9 in diabetic patients with CIDP. Neurology 61: 1607-1610.
34. Joint Task Force of the EFNS and the PNS (2010a). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision. J Peripher Nerv Syst 15: 1-9.
35. Joint Task Force of the EFNS and the PNS (2010b). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 15: 79-92.
36. Kiefer R, Kieseier BC, Bruck W, Hartung HP, Toyka KV, (1998). Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain 121: 469-479.
37. King R, (1999). Atlas of Peripheral Nerve Pathology. Arnold, London.
38. Kissel JT, Riethman JL, Omerza J, Rammohan KW, Mendell JR, (1989). Peripheral nerve vasculitis: immune characterization of the vascular lesions. Ann Neurol 25: 291-297.
39. Kumar S, Jacob J, (2004). Variability in the extent of sensory deficit after sural nerve biopsy. Neurol India 52: 436-438.
40. Kuwabara S, Misawa S, Kanai K, Kikkawa Y, Nishimura M, Nakaseko C, Cho RK, Hattori T, (2006). Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 66: 105-107.
41. Lauria G, Hsieh ST, Johansson O, Kennedy JM, Leger JM, Mellgren SI, Nolano M, Merkies I, Polydefkis M, Smith AG, Sommer C, Valls-Sole J, (2010). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 17: 903-912, e44-e49.
42. Malik RA, Tesfaye S, Newrick PG, Walker D, Rajbhandari SM, Siddique I, Sharma AK, Boulton AJ, King RH, Thomas PK, Ward JD, (2005). Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48: 578-585.
43. Martinoli C, Bianchi S, Cohen M, Graif M, (2005). Ultrasound of peripheral nerves. J Radiol 86: 1869-1878.
44. Matejas V, Huehne K, Thiel C, Sommer C, Jakubiczka S, Rautenstrauss B, (2006). Identification of Alu elements mediating a partial PMP22 deletion. Neurogenetics 7: 119-126.
45. Meier C, Reulen HJ, Huber P, Mumenthaler M, (1989). Meningoradiculoneuritis mimicking vertebral disc herniation. A "neurosurgical" complication of Lyme-borreliosis. Acta Neurochir (Wien) 98: 42-46.
46. Mellgren SI, Conn DL, Stevens JC, Dyck PJ, (1989). Peripheral neuropathy in primary Sjogren's syndrome. Neurology 39: 390-394.
47. Midroni G, Bilbao JM, (1995). Biopsy Diagnosis of Peripheral Neuropathy. Butterworth-Heinemann, Boston.
48. Miloro M, Stoner JA, (2005). Subjective outcomes following sural nerve harvest. J Oral Maxillofac Surg 63: 1150-1154.
49. Molenaar DS, Vermeulen M, De Haan R, (1998). Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 64: 84-9.
50. Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, Katsuno M, Fujita A, Aiba I, Ogata A, Saito T, Asakura K, Yoshida M, Hirayama M, Sobue G, (2005). The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain 128: 2518-2534.
51. Nemni R, Corbo M, Fazio R, Quattrini A, Comi G, Canal N, (1988). Cryoglobulinaemic neuropathy: a clinical, morphological and immunocytochemical study of 8 cases. Brain 111: 541-552.
52. Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N, (2003). Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry 74: 1267-1271.
53. Neundörfer B, Grahmann F, Engelhardt A, Harte U, (1990). Postoperative effects and value of sural nerve biopsies: a retrospective study. Eur Neurol 30: 350-352.
54. Oh SJ, (1990). Diagnostic usefulness and limitations of the sural nerve biopsy. Yonsei Med J 31: 1-26.
55. Pellissier JF, Pouget J, Cros D, De Victor B, Serratrice G, Toga M, (1984). Peripheral neuropathy induced by amiodarone chlorhydrate. A clinicopathological study. J Neurol Sci 63: 251-266.
56. Perry JR, Bril V, (1994). Complications of sural nerve biopsy in diabetic versus non-diabetic patients. Can J Neurol Sci 21: 34-37.
57. Poburski R, Malin JP, Stark E, (1985). Sequelae of sural nerve biopsies. Clin Neurol Neurosurg 87: 193-198.
58. Pollock M, Nukada H, Taylor P, Donaldson I, Carroll G, (1983). Comparison between fascicular and whole sural nerve biopsy. Ann Neurol 13: 65-68.
59. Rappaport WD, Valente J, Hunter GC, Rance NE, Lick S, Lewis T, Neal D, (1993). Clinical utilization and complications of sural nerve biopsy. Am J Surg 166: 252-256.
60. Ritz MF, Erne B, Ferracin F, Vital A, Vital C, Steck AJ, (1999). Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening. Muscle Nerve 22: 1030-1037.
61. Ruth A, Schulmeyer FJ, Roesch M, Woertgen C, Brawanski A, (2005). Diagnostic and therapeutic value due to suspected diagnosis, long-term complications, and indication for sural nerve biopsy. Clin Neurol Neurosurg 107: 214-217.
62. Said G, Lacroix C, (2005). Primary and secondary vasculitic neuropathy. J Neurol 252: 633-641.
63. Schäfers M, Neukirchen S, Toyka KV, Sommer C, (2008). Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy. J Peripher Nerv Syst 13: 81-91.
64. Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J, (1996). Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 19: 474-487.
65. Schoeller T, Huemer GM, Shafighi M, Gurunluoglu R, Wechselberger G, Piza-Katzer H, (2004). Microsurgical repair of the sural nerve after nerve biopsy to avoid associated sensory morbidity: a preliminary report. Neurosurgery 54: 897-900.
66. Schröder JM, (2001). Pathology of Peripheral Nerves: An Atlas of Structural and Molecular Pathological Changes. Springer, Heidelberg.
67. Schröder JM, Matthiesen T, (1985). Experimental thalidomide neuropathy: the morphological correlate of reduced conduction velocity. Acta Neuropathol 65: 285-292.
68. Schröder JM, Sellhaus B, Jorg J, (1995). Identification of the characteristic vascular changes in a sural nerve biopsy of a case with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Acta Neuropathol 89: 116-121.
69. Schwartz AM, Henson DE, (2007). Diagnostic surgical pathology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132: 78S-93S.
70. Senderek J, Bergmann C, Ramaekers VT, Nelis E, Bernert G, Makowski A, Zuchner S, De Jonghe P, Rudnik-Schoneborn S, Zerres K, Schroder JM, (2003a). Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy. Brain 126: 642-649.
71. Senderek J, Bergmann C, Weber S, Ketelsen UP, Schorle H, Rudnik-Schoneborn S, Buttner R, Buchheim E, Zerres K, (2003b). Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet 12: 349-356.
72. Sommer C, Lauria G, (2007). Skin biopsy in the management of peripheral neuropathy. Lancet Neurol 6: 632-642.
73. Sommer C, Koch S, Lammens M, Gabreels-Festen A, Stoll G, Toyka KV, (2005). Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP. Neurology 65: 1924-1929.
74. Sommer C, Brandner S, Dyck PJ, Magy L, Mellgren SI, Morbin M, Schenone A, Tan E, Weis J, (2008). 147th ENMC International Workshop: guideline on processing and evaluation of sural nerve biopsies, 15-17 December 2006, Naarden, The Netherlands. Neuromuscul Disord 18: 90-96.
75. Soubrier MJ, Dubost JJ, Sauvezie BJ, (1994). POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS syndrome. Am J Med 97: 543-553.
76. Theriault M, Dort J, Sutherland G, Zochodne DW, (1998). A prospective quantitative study of sensory deficits after whole sural nerve biopsies in diabetic and nondiabetic patients. Surgical approach and the role of collateral sprouting. Neurology 50: 480-484.
77. Vallat JM, Hugon J, Lubeau M, Leboutet MJ, Dumas M, Desproges-Gotteron R, (1987). Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases. Neurology 37: 749-753.
78. Vallat JM, De MH, Bordessoule D, Jauberteau MO, Tabaraud F, Gelot A, (1995). Non-Hodgkin malignant lymphomas and peripheral neuropathies-13 cases. Brain 118: 1233-1245.
79. Vallat JM, Tabaraud F, Magy L, Torny F, Bernet-Bernady P, Macian F, Couratier P, (2003). Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve 27: 478-485.
80. Vedeler CA, Antoine JC, Giometto B, Graus F, Grisold W, Hart IK, Honnorat J, Sillevis Smitt PA, Verschuuren JJ, Voltz R, (2006). Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol 13: 682-690.
81. Vital A, Vital C, Julien J, Baquey A, Steck AJ, (1989). Polyneuropathy associated with IgM monoclonal gammopathy. Immunological and pathological study in 31 patients. Acta Neuropathol 79: 160-167.
82. Vital C, Vallat JM, (1987). Ultrastructural Study of the Human Diseased Peripheral Nerve. Elsevier, New York.
83. Vital C, Gherardi R, Vital A, Kopp N, Pellissier JF, Soubrier M, Clavelou P, Bellance R, Delisle MB, Ruchoux MM, Hauw JJ, (1994). Uncompacted myelin lamellae in polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes syndrome. Ultrastructural study of peripheral nerve biopsy from 22 patients. Acta Neuropathol 87: 302-307.
84. Vital C, Vital A, Lagueny A, Ferrer X, Fontan D, Barat M, Gbikpi-Benissan G, Orgogozo JM, Henry P, Brechenmacher C, Bredin A, Desbordes P, Ribiere-Bachelier C, Latinville D, Julien J, Petry KG, (2000). Chronic inflammatory demyelinating polyneuropathy: immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases. Ultrastruct Pathol 24: 363-369.
85. Vital C, Vital A, Ferrer X, Viallard JF, Pellegrin JL, Bouillot S, Larrieu JM, Lequen L, Larrieu JL, Brechenmacher C, Petry KG, Lagueny A, (2003). Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases. J Peripher Nerv Syst 8: 136-144.
86. Vital C, Vital A, Canron MH, Jaffre A, Viallard JF, Ragnaud JM, Brechenmacher C, Lagueny A, (2006). Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst 11: 20-29.
87. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I, (1996). Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome. Lancet 347: 702.
88. Willison HJ, Yuki N, (2002). Peripheral neuropathies and anti-glycolipid antibodies. Brain 125: 2591-2625.
89. Yeung KB, Thomas PK, King RH, Waddy H, Will RG, Hughes RA, Gregson NA, Leibowitz S, (1991). The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol 238: 383-391.
90. Zimmerman IR, Karnes JL, O'Brien PC, Dyck PJ, (1980). Imaging system for nerve and fiber tract morphometry: components, approaches, performance, and results. J Neuropathol Exp Neurol 39: 409-419.